Latest papers

Safety, tolerability, and immunologic effects of a food allergy herbal formula in food allergic individuals: a randomized, double-blinded, placebo-controlled, dose escalation, phase 1 study.

Subconjunctival triamcinolone treatment for non-necrotising anterior scleritis.

RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline.

Hepatoprotective effect of tumour necrosis factor alpha blockade in psoriatic arthritis: a cross-sectional study.

Long-term visual and anatomical outcomes following anti-VEGF monotherapy for retinal angiomatous proliferation.

[The efficacy of propafenon in the case of supraventricular atrioventricular tachycardia].

Pharmacology and efficacy of asenapine for manic and mixed states in adults with bipolar disorder.

Infliximab for the treatment of refractory scleritis.

International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 10 on Polyacrylamide Gel Electrophoresis General Chapter; availability. Notice.

Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care.

Formulation and evaluation of mouth dissolving tablets of the Etoricoxib.

A look back at 2009: one step forward, two steps back.

Infliximab safety profile and long-term applicability in inflammatory bowel disease: 9-year experience in clinical practice.

Tigecycline in the treatment of ventilator-associated pneumonia: experience from the Latin American Tigecycline Use Registry.

Head of German cost-effectiveness institute forced to quit.

[Evaluation of low-dose amphotericin B and flucytosine in the treatment of cryptococcal meningitis].

Enhancement of the efficacy of therapeutic proteins by formulation with PEGylated liposomes; a case of FVIII, FVIIa and G-CSF.

Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action.

The TRITON versus PLATO trials: differences beyond platelet inhibition.

Polymeric micelles as a new drug carrier system and their required considerations for clinical trials.